[1]
О. О. Карпенко, “Pharmacogenetic testing for CYP2C19 gene polymorphism for optimization of using antiplatelet therapy in patients with ischemic heart disease”, ScienceRise: Medical Science, no. 8 (4), pp. 15–20, Aug. 2016.